NCT03360838 Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool
| NCT ID | NCT03360838 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Postoperative Delirium |
| Study Type | OBSERVATIONAL |
| Enrollment | 475 participants |
| Start Date | 2018-04-16 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 475 participants in total. It began in 2018-04-16 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational cohort study is designed to validate the CogCheck application as a risk prediction tool for postoperative delirium in patients undergoing cardiac surgery.
Eligibility Criteria
Inclusion Criteria: * Elective cardiac surgery * Age ≥60 years * Good knowledge of the German language * Written informed consent Exclusion Criteria: * Emergency surgery * Medical instability limiting preoperative assessment * Surgical procedures without the use of cardiopulmonary bypass * Procedures involving deep hypothermic circulatory arrest * Concurrent carotid surgical procedures * Participation in an interventional trial with POD or POCD as primary endpoint
Contact & Investigator
Luzius Steiner, MD, PhD
STUDY CHAIR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT03360838 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Postoperative Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03360838 currently recruiting?
Yes, NCT03360838 is actively recruiting participants. Contact the research team at nicolai.goettel@usb.ch for enrollment information.
Where is the NCT03360838 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT03360838 clinical trial?
NCT03360838 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Luzius Steiner, MD, PhD at University Hospital, Basel, Switzerland. The trial plans to enroll 475 participants.